Appetite- and Weight-Regulating Neuroendocrine Circuitry in Hypothalamic Obesity
Open accessThe DOI matches its Crossref record; 127 of the 127 references it cites were found in a registry or an index.
Abstract
Since hypothalamic obesity (HyOb) was first described over 120 years ago by Joseph Babinski and Alfred Fröhlich, advances in molecular genetic laboratory techniques have allowed us to elucidate various components of the intricate neurocircuitry governing appetite and weight regulation connecting the hypothalamus, pituitary gland, brainstem, adipose tissue, pancreas, and gastrointestinal tract. On a background of an increasing prevalence of population-level common obesity, the number of survivors of congenital (eg, septo-optic dysplasia, Prader–Willi syndrome) and acquired (eg, central nervous system tumors) hypothalamic disorders is increasing, thanks to earlier diagnosis and management as well as better oncological therapies. Although to date the discovery of several appetite-regulating peptides has led to the development of a range of targeted molecular therapies for monogenic obesity syndromes, outside of these disorders these discoveries have not translated into the development of efficacious treatments for other forms of HyOb. This review aims to summarize our current understanding of the neuroendocrine physiology of appetite and weight regulation, and explore our current understanding of the pathophysiology of HyOb.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity
de Lecea, L., Kilduff, T. S., Peyron, C., Gao, X.-B., Foye, P. E., Danielson, P. E., Fukuhara, C., Battenberg, E. L. F., Gautvik, V. T., Bartlett, F. S., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.1.322 · Cited by 3,878 · cited 2×
“Hcrt expression has been found in the LHA (particularly the perifornical area), DMN, and ventral thalamus, with neurons projecting widely, including to the PVN, locus coeruleus, and NTS (372-375).”
Neurons containing hypocretin (orexin) project to multiple neuronal systems
Peyron, C., Tighe, D. K., van den Pol, A. N., de Lecea, L., Heller, H. C., Sutcliffe, J. G., & Kilduff, T. S. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-23-09996.1998 · Cited by 3,466 · cited 1×
“Hcrt expression has been found in the LHA (particularly the perifornical area), DMN, and ventral thalamus, with neurons projecting widely, including to the PVN, locus coeruleus, and NTS (372-375).”
A role for ghrelin in the central regulation of feeding
Nakazato, M., Murakami, N., Date, Y., Kojima, M., Matsuo, H., Kangawa, K., & Matsukura, S. (2001) · Nature · doi:10.1038/35051587 · Cited by 3,443 · cited 4×
“Indeed, administration of insulin and leptin both result in a reduction of NPY expression in the ARC, while ghrelin has the opposite effect (77, 316, 358).”
InfluentialRole of leptin in the neuroendocrine response to fasting
Ahima, R. S., Prabakaran, D., Mantzoros, C., Qu, D., Lowell, B., Maratos-Flier, E., & Flier, J. S. (1996) · Nature · doi:10.1038/382250a0 · Cited by 3,117
Narcolepsy in orexin Knockout Mice
Chemelli, R. M., Willie, J. T., Sinton, C. M., Elmquist, J. K., Scammell, T., Lee, C., Richardson, J. A., Williams, S. C., Xiong, Y., Kisanuki, Y., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)81973-x · Cited by 3,095 · cited 1×
“Hcrt − / − mice exhibit sleep dysregulation, with sleep-onset rapid eye movement and more fragmented non-rapid eye movement sleep (378).”
The oxytocin receptor system: structure, function, and regulation
Gimpl, G., & Fahrenholz, F. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.629 · Cited by 3,089
Targeted disruption of the melanocortin-4 receptor results in obesity in mice
Huszar, D., Lynch, C. A., Fairchild-Huntress, V., Dunmore, J. H., Fang, Q., Berkemeier, L. R., Gu, W., Kesterson, R. A., Boston, B. A., Cone, R. D., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)81865-6 · Cited by 3,030 · cited 2×
“Mc4r − / − knockout mice develop severe hyperphagia and obesity (105), and dominant mutations in MC4R have been shown to be the most common cause of monogenic obesity in humans (106, 107).”
Critical nodes in signalling pathways: insights into insulin action
Taniguchi, C. M., Emanuelli, B., & Kahn, C. R. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1837 · Cited by 2,760
Gut hormone PYY3-36 physiologically inhibits food intake
Batterham, R. L., Cowley, M. A., Small, C. J., Herzog, H., Cohen, M. A., Dakin, C. L., Wren, A. M., Brynes, A. E., Low, M. J., Ghatei, M. A., et al. (2002) · Nature · doi:10.1038/nature00887 · Cited by 2,351
A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction
Clément, K., Vaisse, C., Lahlou, N., Cabrol, S., Pelloux, V., Cassuto, D., Gourmelen, M., Dina, C., Chambaz, J., Lacorte, J.-M., et al. (1998) · Nature · doi:10.1038/32911 · Cited by 2,346
Role of Brain Insulin Receptor in Control of Body Weight and Reproduction
Brüning, J. C., Gautam, D., Burks, D. J., Gillette, J., Schubert, M., Orban, P. C., Klein, R., Krone, W., Müller-Wieland, D., & Kahn, C. R. (2000) · Science · doi:10.1126/science.289.5487.2122 · Cited by 2,235
Hypothalamic integration: organization of the paraventricular and supraoptic nuclei
Swanson, L. W., & Sawchenko, P. E. (1983) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.06.030183.001413 · Cited by 1,991
A role for glucagon-like peptide-1 in the central regulation of feeding
Turton, M. D., O'Shea, D., Gunn, I., Beak, S. A., Edwards, C. M. B., Meeran, K., Choi, S. J., Taylor, G. M., Heath, M. M., Lambert, P. D., et al. (1996) · Nature · doi:10.1038/379069a0 · Cited by 1,950
Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein
Ollmann, M. M., Wilson, B. D., Yang, Y.-K., Kerns, J. A., Chen, Y., Gantz, I., & Barsh, G. S. (1997) · Science · doi:10.1126/science.278.5335.135 · Cited by 1,881
Purification of a new neurotrophic factor from mammalian brain.
Barde, Y. A., Edgar, D., & Thoenen, H. (1982) · The EMBO Journal · doi:10.1002/j.1460-2075.1982.tb01207.x · Cited by 1,822 · cited 17×
“Abbreviations: 5-HT, serotonin; α MSH, α -melanocyte stimulating hormone; ACTH, adrenocorticotropic hormone; AgRP, Agouti-related peptide; ARC, arcuate nucleus; AVP, arginine–vasopressin; BDNF, brain-derived neurotrophic factor; BMI, body mass index; CART, cocaine-and amphetamine-regulated transcript; CCK, cholecystok…”
InfluentialChang, S.-H., Stoll, C. R. T., Song, J., Varela, J. E., Eagon, C. J., & Colditz, G. A. (2014) · JAMA Surgery · doi:10.1001/jamasurg.2013.3654 · Cited by 1,688
Inhibition of Food Intake in Obese Subjects by Peptide YY 3–36
Batterham, R. L., Cohen, M. A., Ellis, S. M., Le Roux, C. W., Withers, D. J., Frost, G. S., Ghatei, M. A., & Bloom, S. R. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030204 · Cited by 1,604 · cited 1×
“Importantly, although human obesity is associated with PYY deficiency, PYY 3-36 retains its anorexigenic effects in this group, without the development of resistance like that seen with leptin (208, 209).”
Hippocampal long-term potentiation is impaired in mice lacking brain-derived neurotrophic factor.
Korte, M., Carroll, P., Wolf, E., Brem, G., Thoenen, H., & Bonhoeffer, T. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.19.8856 · Cited by 1,426 · cited 1×
“However, the role of BDNF in regulating appetite and weight has proven difficult to study due to its crucial role in the nervous system, with Bdnf − / − mice exhibiting early postnatal lethality (132, 133).”
Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans.
Flint, A., Raben, A., Astrup, A., & Holst, J. J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci990 · Cited by 1,402
Prader-Willi Syndrome: Consensus Diagnostic Criteria
Holm, V. A., Cassidy, S. B., Butler, M. G., Hanchett, J. M., Greenswag, L. R., Whitman, B. Y., & Greenberg, F. (1993) · Pediatrics · doi:10.1542/peds.91.2.398 · Cited by 1,278 · cited 1×
“…a poor suck and poor weight gain in infancy (usually requiring nutritional support), followed by rapid-onset weight gain and hy-perphagia in childhood, characteristic facial dysmorphisms, hypogonadism, developmental delay or learning difficulties, and 1 of the genetic defects described above (448).”
Orexin A activates locus coeruleus cell firing and increases arousal in the rat
Hagan, J. J., Leslie, R. A., Patel, S., Evans, M. L., Wattam, T. A., Holmes, S., Benham, C. D., Taylor, S. G., Routledge, C., Hemmati, P., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.19.10911 · Cited by 1,234 · cited 1×
“Additionally, the locus coeruleus is densely innervated by hypocretin-secreting neurons, which increase its noradrenergic output as well as arousal and locomotor activity in rats (374).”
Yang, W.-S., Lee, W.-J., Funahashi, T., Tanaka, S., Matsuzawa, Y., Chao, C.-L., Chen, C.-L., Tai, T.-Y., & Chuang, L.-M. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.8.3815 · Cited by 1,181
Coexpression of Agrp and NPY in fasting-activated hypothalamic neurons
Hahn, T. M., Breininger, J. F., Baskin, D. G., & Schwartz, M. W. (1998) · Nature Neuroscience · doi:10.1038/1082 · Cited by 1,164 · cited 4×
“…has been demonstrated in the neuronal plexi of the small and large intestines, the sympathetic neurons of the autonomic nervous system, the spinal cord, SON, PVN, DMN, NTS, medulla, locus coeruleus, hippocampus, amygdala, basal ganglia, nucleus accumbens, and cerebral cortex (192, 330, 343-350).”
InfluentialA frameshift mutation in MC4R associated with dominantly inherited human obesity
Yeo, G. S. H., Farooqi, I. S., Aminian, S., Halsall, D. J., Stanhope, R. G., & O'Rahilly, S. (1998) · Nature Genetics · doi:10.1038/2404 · Cited by 1,159
Sawchenko, P. E., & Swanson, L. W. (1982) · Journal of Comparative Neurology · doi:10.1002/cne.902050306 · Cited by 1,150
Hypothalamic and genetic obesity in experimental animals: an autonomic and endocrine hypothesis
Bray, G. A., & York, D. A. (1979) · Physiological Reviews · doi:10.1152/physrev.1979.59.3.719 · Cited by 1,132
Chronic intracerebroventricular infusion of insulin reduces food intake and body weight of baboons
Woods, S. C., Lotter, E. C., McKay, L. D., & Porte, D. (1979) · Nature · doi:10.1038/282503a0 · Cited by 1,114
Farooqi, I. S., Matarese, G., Lord, G. M., Keogh, J. M., Lawrence, E., Agwu, C., Sanna, V., Jebb, S. A., Perna, F., Fontana, S., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215693 · Cited by 1,105
OBESE, A NEW MUTATION IN THE HOUSE MOUSE*
INGALLS, A. M., DICKIE, M. M., & SNELL, G. D. (1950) · Journal of Heredity · doi:10.1093/oxfordjournals.jhered.a106073 · Cited by 1,090
Mice lacking brain-derived neurotrophic factor develop with sensory deficits
Ernfors, P., Lee, K.-F., & Jaenisch, R. (1994) · Nature · doi:10.1038/368147a0 · Cited by 1,067 · cited 1×
“However, the role of BDNF in regulating appetite and weight has proven difficult to study due to its crucial role in the nervous system, with Bdnf − / − mice exhibiting early postnatal lethality (132, 133).”
Gut-expressed gustducin and taste receptors regulate secretion of glucagon-like peptide-1.
Jang, H.-J., Kokrashvili, Z., Theodorakis, M. J., Carlson, O. D., Kim, B.-J., Zhou, J., Kim, H. H., Xu, X., Chan, S. L., Juhaszova, M., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706890104 · Cited by 995 · cited 1×
“GLP-1 is secreted by enteroendocrine L cells in response to the presence of glucose, potentiating insulin secretion, delaying gastric emptying, and suppressing orexigenic pathways in the hypothalamus and NTS (145, 146, 149, 161, 163).”
Diabetes, a New Mutation in the Mouse
Hummel, K. P., Dickie, M. M., & Coleman, D. L. (1966) · Science · doi:10.1126/science.153.3740.1127 · Cited by 990
Vilsboll, T., Christensen, M., Junker, A. E., Knop, F. K., & Gluud, L. L. (2012) · BMJ · doi:10.1136/bmj.d7771 · Cited by 970 · cited 1×
“Administration of exogenous GLP-1 in humans causes increased satiety, reduced food intake, delayed gastric emptying, and improved glucose tolerance (161-164), with a recent meta-analysis of 25 studies showing an overall effect of weight loss (165).”
Effect of Sibutramine on Cardiovascular Outcomes in Overweight and Obese Subjects
James, W. P. T., Caterson, I. D., Coutinho, W., Finer, N., Van Gaal, L. F., Maggioni, A. P., Torp-Pedersen, C., Sharma, A. M., Shepherd, G. M., Rode, R. A., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003114 · Cited by 943 · cited 1×
“Of these a meta-analysis demonstrated that sibutramine showed the biggest overall effect on BMI reduction (mean difference − 1.70 kg/m 2 (95% CI − 2.89 to − 0.51), P .00001), but this drug has been with-drawn from both European and US markets due to adverse cardiovascular events (498, 501).”
InfluentialThorens, B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.18.8641 · Cited by 906
Schwartz, M. W., Baskin, D. G., Bukowski, T. R., Kuijper, J. L., Foster, D., Lasser, G., Prunkard, D. E., Porte, D., Woods, S. C., Seeley, R. J., et al. (1996) · Diabetes · doi:10.2337/diab.45.4.531 · Cited by 904
Hypothalamic insulin signaling is required for inhibition of glucose production
Obici, S., Zhang, B. B., Karkanias, G., & Rossetti, L. (2002) · Nature Medicine · doi:10.1038/nm1202-798 · Cited by 904 · cited 1×
“The discovery of insulin as a treatment for diabetes mellitus has been known for decades and is a longstanding historical landmark in the field of endocrinology (23), but its role in hypo-thalamic signaling and the regulation of appetite has only been recently deciphered (69-71).”
Brain-derived neurotrophic factor regulates energy balance downstream of melanocortin-4 receptor
Xu, B., Goulding, E. H., Zang, K., Cepoi, D., Cone, R. D., Jones, K. R., Tecott, L. H., & Reichardt, L. F. (2003) · Nature Neuroscience · doi:10.1038/nn1073 · Cited by 896
Ghrelin Strongly Stimulates Growth Hormone Release in Humans
Takaya, K., Ariyasu, H., Kanamoto, N., Iwakura, H., Yoshimoto, A., Harada, M., Mori, K., Komatsu, Y., Usui, T., Shimatsu, A., et al. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.12.7167 · Cited by 864 · cited 3×
“Other peptides such as CRH, GHRH, TRH, somatostatin (SS), resistin, interleukin-1 β , and 5-HT have also been described in the literature as having appetite-and/or weight-regulating effects but will not be discussed here (40, 41, 329, 402-404).”
Glenn Stanley, B., Kyrkouli, S. E., Lampert, S., & Leibowitz, S. F. (1986) · Peptides · doi:10.1016/0196-9781(86)90149-x · Cited by 849
Adiponectin Stimulates AMP-Activated Protein Kinase in the Hypothalamus and Increases Food Intake
Kubota, N., Yano, W., Kubota, T., Yamauchi, T., Itoh, S., Kumagai, H., Kozono, H., Takamoto, I., Okamoto, S., Shiuchi, T., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.06.003 · Cited by 844
Synthesis, transport, and release of posterior pituitary hormones
Brownstein, M. J., Russell, J. T., & Gainer, H. (1980) · Science · doi:10.1126/science.6153132 · Cited by 838 · cited 1×
“…neurophysin I, such that OXT is synthesized as preproOXT-protein neurophysin I, which is then proteolytically cleaved by PC1/3 and PC2 during axonal transport from the hypothalamus to the posterior pituitary where it is stored until secretion, whereupon the free OXT peptide dissociates (232-238).”
The role of incretins in glucose homeostasis and diabetes treatment
Kim, W., & Egan, J. M. (2008) · Pharmacological Reviews · doi:10.1124/pr.108.000604 · Cited by 824 · cited 1×
“Glucagon-like peptide-1 GLP-1 is 1 of 2 incretins secreted by the gut to stimulate insulin secretion in response to food (142).”
Adiponectin acts in the brain to decrease body weight
Qi, Y., Takahashi, N., Hileman, S. M., Patel, H. R., Berg, A. H., Pajvani, U. B., Scherer, P. E., & Ahima, R. S. (2004) · Nature Medicine · doi:10.1038/nm1029 · Cited by 809
BDNF regulates eating behavior and locomotor activity in mice
Kernie, S. G., Liebl, D. J., & Parada, L. F. (2000) · The EMBO Journal · doi:10.1093/emboj/19.6.1290 · Cited by 806 · cited 4×
“The first clue to the role of BDNF in appetite–weight homeostasis appeared in studies of heterozygous Bdnf +/ − mice, where food intake and weight (particularly fat mass) were increased over time, and serotonergic transmission was dysregulated (130, 134).”
InfluentialFeast and Famine: Critical Role of Glucocorticoids with Insulin in Daily Energy Flow
Dallman, M. F., Strack, A. M., Akana, S. F., Bradbury, M. J., Hanson, E. S., Scribner, K. A., & Smith, M. (1993) · Frontiers in Neuroendocrinology · doi:10.1006/frne.1993.1010 · Cited by 796 · cited 1×
“The PVN is also responsible for secreting TRH, CRH, and OXT, all of which are able to suppress food intake and/or increase energy expenditure (40, 118, 119, 329, 402, 410, 411).”
Proopiomelanocortin Neurons Are Direct Targets for Leptin in the Hypothalamus
Cheung, C. C., Clifton, D. K., & Steiner, R. A. (1997) · Endocrinology · doi:10.1210/endo.138.10.5570 · Cited by 769 · cited 1×
“The role of leptin in regulating POMC vs AgRP/NPY secretion is further supported by the coexpression of leptin receptors on both of these neuronal subsets (65, 66).”
Fei, H., Okano, H. J., Li, C., Lee, G.-H., Zhao, C., Darnell, R., & Friedman, J. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.13.7001 · Cited by 766
Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass
le Roux, C. W., Welbourn, R., Werling, M., Osborne, A., Kokkinos, A., Laurenius, A., Lönroth, H., Fändriks, L., Ghatei, M. A., Bloom, S. R., et al. (2007) · Annals of Surgery · doi:10.1097/sla.0b013e3180caa3e3 · Cited by 741 · cited 2×
“The increase in PYY and GLP-1 secretion is thought to be a major factor in the sustained weight loss observed after gastric by-pass surgery (166, 167, 212).”
Ozata, M., Ozdemir, I. C., & Licinio, J. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.10.5999 · Cited by 739 · cited 1×
“For instance, congenital leptin deficiency and leptin receptor mutations both result additionally in hypogonadotropic hypogonadism (in contrast to common obesity where puberty is often early (14, 15, 45, 426).”
Decreasing hypothalamic insulin receptors causes hyperphagia and insulin resistance in rats
Obici, S., Feng, Z., Karkanias, G., Baskin, D. G., & Rossetti, L. (2002) · Nature Neuroscience · doi:10.1038/nn0602-861 · Cited by 719 · cited 1×
“Reduction of Insr expression in the hypothalamus by antisense oligonucleotides in rats, and conditionally knocking out INSR in neuronal tissues in mice both result in increased appetite and weight gain (74, 75).”
Pruunsild, P., Kazantseva, A., Aid, T., Palm, K., & Timmusk, T. (2007) · Genomics · doi:10.1016/j.ygeno.2007.05.004 · Cited by 699 · cited 1×
“As a member of the nerve growth factor (neurotrophin) family, it has a major role in neuronal survival and neuroprotection, and is therefore widely expressed (126-129).”
Larsen, P. J., Tang-Christensen, M., Holst, J. J., & Ørskov, C. (1997) · Neuroscience · doi:10.1016/s0306-4522(96)00434-4 · Cited by 663
Fos Expression in Orexin Neurons Varies with Behavioral State
Estabrooke, I. V., McCarthy, M. T., Ko, E., Chou, T. C., Chemelli, R. M., Yanagisawa, M., Saper, C. B., & Scammell, T. E. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-05-01656.2001 · Cited by 654
Hamster preproglucagon contains the sequence of glucagon and two related peptides
Bell, G. I., Santerre, R. F., & Mullenbach, G. T. (1983) · Nature · doi:10.1038/302716a0 · Cited by 649 · cited 22×
“Abbreviations: 5-HT, serotonin; α MSH, α -melanocyte stimulating hormone; ACTH, adrenocorticotropic hormone; AgRP, Agouti-related peptide; ARC, arcuate nucleus; AVP, arginine–vasopressin; BDNF, brain-derived neurotrophic factor; BMI, body mass index; CART, cocaine-and amphetamine-regulated transcript; CCK, cholecystok…”
InfluentialCraniopharyngiomas in children and adults: systematic analysis of 121 cases with long-term follow-up
Karavitaki, N., Brufani, C., Warner, J. T., Adams, C. B. T., Richards, P., Ansorge, O., Shine, B., Turner, H. E., & Wass, J. A. H. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02231.x · Cited by 633 · cited 1×
“It is worth noting that 5-year survival for this subgroup of pediatric CNS tumors is high, particularly as the 2 commonest histologies found in this region are benign (craniopharyngio-mas 95%, low-grade gliomas 96% (31, 490)).”
Leptin inhibits hypothalamic neurons by activation of ATP-sensitive potassium channels
Spanswick, D., Smith, M. A., Groppi, V. E., Logan, S. D., & Ashford, M. L. J. (1997) · Nature · doi:10.1038/37379 · Cited by 628 · cited 1×
“…the latter pathway is common to both leptin and insulin signaling, with both hormones stimulating POMC neurons, and leptin additionally inhibiting AgRP neurons (61, 62) Furthermore, leptin suppresses the FOXO1-stimulated expression of NPY and AgRP and FOXO1-inhibited expression of POMC (63, 64).”
Large, rare chromosomal deletions associated with severe early-onset obesity
Bochukova, E. G., Huang, N., Keogh, J., Henning, E., Purmann, C., Blaszczyk, K., Saeed, S., Hamilton-Shield, J., Clayton-Smith, J., O’Rahilly, S., et al. (2010) · Nature · doi:10.1038/nature08689 · Cited by 613 · cited 1×
“Finally, mutations in genes affecting hypothalamic development ( SIM1 ), post-translational processing of appetite-regulating hormones ( PCSK1 ), or common downstream signaling pathways ( SH2B1 ) lead to HyOb through their impact on multiple appetite-and weight-regulating hormones (429, 435, 438).”
Central administration of GLP-1-(7-36) amide inhibits food and water intake in rats
Tang-Christensen, M., Larsen, P. J., Goke, R., Fink-Jensen, A., Jessop, D. S., Moller, M., & Sheikh, S. P. (1996) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1996.271.4.r848 · Cited by 597
Exon duplication and divergence in the human preproglucagon gene
Bell, G. I., Sanchez-Pescador, R., Laybourn, P. J., & Najarian, R. C. (1983) · Nature · doi:10.1038/304368a0 · Cited by 593
Rossi, M., Kim, M. S., Morgan, D. G. A., Small, C. J., Edwards, C. M. B., Sunter, D., Abusnana, S., Goldstone, A. P., Russell, S. H., Stanley, S. A., et al. (1998) · Endocrinology · doi:10.1210/endo.139.10.6332 · Cited by 576
Inhibition of hypothalamic neuropeptide Y gene expression by insulin.
Schwartz, M. W., Sipols, A. J., Marks, J. L., Sanacora, G., White, J. D., Scheurink, A., Kahn, S. E., Baskin, D. G., Woods, S. C., & Figlewicz, D. P. (1992) · Endocrinology · doi:10.1210/endo.130.6.1597158 · Cited by 555
Willms, B., Werner, J., Holst, J. J., Orskov, C., Creutzfeldt, W., & Nauck, M. A. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.1.8550773 · Cited by 502
Neuropeptide, Y, peptide YY and pancreatic polypeptide in the gut-brain axis
Holzer, P., Reichmann, F., & Farzi, A. (2012) · Neuropeptides · doi:10.1016/j.npep.2012.08.005 · Cited by 501 · cited 2×
“…has been demonstrated in the neuronal plexi of the small and large intestines, the sympathetic neurons of the autonomic nervous system, the spinal cord, SON, PVN, DMN, NTS, medulla, locus coeruleus, hippocampus, amygdala, basal ganglia, nucleus accumbens, and cerebral cortex (192, 330, 343-350).”
Pancreatic Polypeptide Reduces Appetite and Food Intake in Humans
Batterham, R. L., Le Roux, C. W., Cohen, M. A., Park, A. J., Ellis, S. M., Patterson, M., Frost, G. S., Ghatei, M. A., & Bloom, S. R. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030630 · Cited by 496
Insulin activates ATP-sensitive K+ channels in hypothalamic neurons of lean, but not obese rats
Spanswick, D., Smith, M. A., Mirshamsi, S., Routh, V. H., & Ashford, M. L. J. (2000) · Nature Neuroscience · doi:10.1038/77660 · Cited by 495 · cited 2×
“Insulin has been shown to inhibit hypothalamic Npy and Agrp expression, and to increase Pomc neuronal activation in rodent models in concert with leptin through PI3K/ PKB (AKT)/FOXO1 signaling (61, 63, 76-79).”
Proopiomelanocortin Deficiency Treated with a Melanocortin-4 Receptor Agonist
Kühnen, P., Clément, K., Wiegand, S., Blankenstein, O., Gottesdiener, K., Martini, L. L., Mai, K., Blume-Peytavi, U., Grüters, A., & Krude, H. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1512693 · Cited by 485
Energy intake and appetite are suppressed by glucagon-like peptide-1 (GLP-1) in obese men.
Näslund, E., Barkeling, B., King, N., Gutniak, M., Blundell, J., Holst, J., Rössner, S., & Hellström, P. (1999) · International Journal of Obesity · doi:10.1038/sj.ijo.0800818 · Cited by 468 · cited 1×
“GLP-1 is secreted by enteroendocrine L cells in response to the presence of glucose, potentiating insulin secretion, delaying gastric emptying, and suppressing orexigenic pathways in the hypothalamus and NTS (145, 146, 149, 161, 163).”
Striepens, N., Kendrick, K. M., Hanking, V., Landgraf, R., Wüllner, U., Maier, W., & Hurlemann, R. (2013) · Scientific Reports · doi:10.1038/srep03440 · Cited by 452
Whittington, J. E., Holland, A. J., Webb, T., Butler, J., Clarke, D., & Boer, H. (2001) · Journal of Medical Genetics · doi:10.1136/jmg.38.11.792 · Cited by 451 · cited 1×
“Prader–Willi syndrome is, in effect, a contiguous gene deletion syndrome of the paternal copies of several imprinted genes in the 15q11-13 region ( SNRPN , NDN , MAGEL2 , MKRN3 , SNORD116 ), with a birth incidence of 1 in 20 000 and an overall population prevalence of 1 in 52 000 (445).”
Varela, L., & Horvath, T. L. (2012) · The EMBO Reports · doi:10.1038/embor.2012.174 · Cited by 426 · cited 2×
“Insulin has been shown to inhibit hypothalamic Npy and Agrp expression, and to increase Pomc neuronal activation in rodent models in concert with leptin through PI3K/ PKB (AKT)/FOXO1 signaling (61, 63, 76-79).”
Bagnol, D., Lu, X.-Y., Kaelin, C. B., Day, H. E. W., Ollmann, M., Gantz, I., Akil, H., Barsh, G. S., & Watson, S. J. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-18-j0004.1999 · Cited by 425 · cited 1×
“Other projections of POMC/CART neurons include the medial preoptic nucleus, DMN, LHA, and the ARC itself, all of which are involved in appetite and weight regulation (120, 121).”
Problems with measuring peripheral oxytocin: can the data on oxytocin and human behavior be trusted?
McCullough, M. E., Churchland, P. S., & Mendez, A. J. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.04.018 · Cited by 416
Sipols, A. J., Baskin, D. G., & Schwartz, M. W. (1995) · Diabetes · doi:10.2337/diab.44.2.147 · Cited by 389
Gut Hormones and Appetite Control: A Focus on PYY and GLP-1 as Therapeutic Targets in Obesity
Silva, A. D., & Bloom, S. R. (2012) · Gut and Liver · doi:10.5009/gnl.2012.6.1.10 · Cited by 373 · cited 1×
“The increase in PYY and GLP-1 secretion is thought to be a major factor in the sustained weight loss observed after gastric by-pass surgery (166, 167, 212).”
Morphology of vasopressin and oxytocin neurones and their central and vascular projections
Sofroniew, M. V. (1983) · Progress in Brain Research · doi:10.1016/s0079-6123(08)64378-2 · Cited by 370 · cited 1×
“Conversely, neurons expressing OXT have also been found outside the hypothalamus indicating that OXT synthesis is not restricted centrally (234, 240, 245-251).”
The neurocircuitry and receptor subtypes mediating anxiolytic-like effects of neuropeptide Y
Kask, A., Harro, J., von Hörsten, S., Redrobe, J. P., Dumont, Y., & Quirion, R. (2002) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(01)00066-5 · Cited by 358
Effects of GLP-1 on appetite and weight
Shah, M., & Vella, A. (2014) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-014-9289-5 · Cited by 352
Sausville, E., Carney, D., & Battey, J. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)39236-0 · Cited by 338
Evaluation of enzyme immunoassay and radioimmunoassay methods for the measurement of plasma oxytocin
Szeto, A., McCabe, P. M., Nation, D. A., Tabak, B. A., Rossetti, M. A., McCullough, M. E., Schneiderman, N., & Mendez, A. J. (2011) · Psychosomatic Medicine · doi:10.1097/psy.0b013e31821df0c2 · Cited by 330
Münzberg, H., Huo, L., Nillni, E. A., Hollenberg, A. N., & Bjørbæk, C. (2003) · Endocrinology · doi:10.1210/en.2002-221037 · Cited by 328 · cited 14×
“Abbreviations: 5-HT, serotonin; α MSH, α -melanocyte stimulating hormone; ACTH, adrenocorticotropic hormone; AgRP, Agouti-related peptide; ARC, arcuate nucleus; AVP, arginine–vasopressin; BDNF, brain-derived neurotrophic factor; BMI, body mass index; CART, cocaine-and amphetamine-regulated transcript; CCK, cholecystok…”
InfluentialInfluence of oxytocin on feeding behavior in the rat
Arletti, R., Benelli, A., & Bertolini, A. (1989) · Peptides · doi:10.1016/0196-9781(89)90082-x · Cited by 328 · cited 1×
“Arletti et al (256). demonstrated that both central (intracere-broventricular) and peripheral (intraperitoneal) administration of OXT resulted in an anorexigenic effect in rats, with these effects being cancelled out by an OXT antagonist.”
Mechanisms of imprinting of the Prader-Willi/Angelman region
Horsthemke, B., & Wagstaff, J. (2008) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.32364 · Cited by 320
Fekete, C., Légrádi, G., Mihály, E., Huang, Q.-H., Tatro, J. B., Rand, W. M., Emerson, C. H., & Lechan, R. M. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-04-01550.2000 · Cited by 308
Rilling, J. K., DeMarco, A. C., Hackett, P. D., Thompson, R., Ditzen, B., Patel, R., & Pagnoni, G. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2011.07.013 · Cited by 303
Meeran, K., O’Shea, D., Edwards, C. M. B., Turton, M. D., Heath, M. M., Gunn, I., Abusnana, S., Rossi, M., Small, C. J., Goldstone, A. P., et al. (1999) · Endocrinology · doi:10.1210/endo.140.1.6421 · Cited by 303
Evaluation of a melanocortin-4 receptor (MC4R) agonist (Setmelanotide) in MC4R deficiency
Collet, T.-H., Dubern, B., Mokrosinski, J., Connors, H., Keogh, J. M., Mendes de Oliveira, E., Henning, E., Poitou-Bernert, C., Oppert, J.-M., Tounian, P., et al. (2017) · Molecular Metabolism · doi:10.1016/j.molmet.2017.06.015 · Cited by 302
Oxytocin receptor-deficient mice developed late-onset obesity
Takayanagi, Y., Kasahara, Y., Onaka, T., Takahashi, N., Kawada, T., & Nishimori, K. (2008) · Neuroreport · doi:10.1097/wnr.0b013e3283021ca9 · Cited by 294
Müller, H. L., Emser, A., Faldum, A., Bruhnken, G., Etavard-Gorris, N., Gebhardt, U., Oeverink, R., Kolb, R., & Sörensen, N. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031751 · Cited by 287
GDF15: a hormone conveying somatic distress to the brain
Lockhart, S. M., Saudek, V., & O’Rahilly, S. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnaa007 · Cited by 256
O'Rahilly, S., Gray, H., Humphreys, P. J., Krook, A., Polonsky, K. S., White, A., Gibson, S., Taylor, K., & Carr, C. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511233332104 · Cited by 237 · cited 1×
“Finally, mutations in genes affecting hypothalamic development ( SIM1 ), post-translational processing of appetite-regulating hormones ( PCSK1 ), or common downstream signaling pathways ( SH2B1 ) lead to HyOb through their impact on multiple appetite-and weight-regulating hormones (429, 435, 438).”
Low sympathetic tone and obese phenotype in oxytocin-deficient mice
Camerino, C. (2009) · Obesity · doi:10.1038/oby.2009.12 · Cited by 235
Structural organization of the human oxytocin receptor gene
Inoue, T., Kimura, T., Azuma, C., Inazawa, J., Takemura, M., Kikuchi, T., Kubota, Y., Ogita, K., & Saji, F. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)31656-9 · Cited by 234 · cited 1×
“3 (252-254), which is expressed in numerous tissues apart from the breast, ovaries, endometrium, and myometrium.”
Oxytocin Reduces Reward-Driven Food Intake in Humans
Ott, V., Finlayson, G., Lehnert, H., Heitmann, B., Heinrichs, M., Born, J., & Hallschmid, M. (2013) · Diabetes · doi:10.2337/db13-0663 · Cited by 226
Treatment of obesity and diabetes using oxytocin or analogs in patients and mouse models
Zhang, H., Wu, C., Chen, Q., Chen, X., Xu, Z., Wu, J., & Cai, D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061477 · Cited by 224
Sofroniew, M. V., & Schrell, U. (1981) · Neuroscience Letters · doi:10.1016/0304-3940(81)90108-7 · Cited by 224
Peripheral oxytocin treatment ameliorates obesity by reducing food intake and visceral fat mass
Maejima, Y., Iwasaki, Y., Yamahara, Y., Kodaira, M., Sedbazar, U., & Yada, T. (2011) · Aging · doi:10.18632/aging.100408 · Cited by 220 · cited 1×
“Intraperitoneal administration of OXT in rats has been shown to cause widespread increased c-fos expression in the PVN, ARC, locus coeruleus, NTS, dorsal nucleus of the vagus, and area postrema, all of which are known to mediate energy homeostasis (260).”
Farooqi, I. S., Volders, K., Stanhope, R., Heuschkel, R., White, A., Lank, E., Keogh, J., O’Rahilly, S., & Creemers, J. W. M. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0687 · Cited by 218
Harz, K. J., Müller, H. L., Waldeck, E., Pudel, V., & Roth, C. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021797 · Cited by 214 · cited 1×
“In studies of acquired causes of HyOb, pediatric patients with craniopharyngiomas have been shown to consume less calories than BMI-matched controls with common obesity, mainly by a reduction in fat intake (418).”
Kagerbauer, S. M., Martin, J., Schuster, T., Blobner, M., Kochs, E. F., & Landgraf, R. (2013) · Journal of Neuroendocrinology · doi:10.1111/jne.12038 · Cited by 212
Oxytocin reduces caloric intake in men
Lawson, E. A., Marengi, D. A., DeSanti, R. L., Holmes, T. M., Schoenfeld, D. A., & Tolley, C. J. (2015) · Obesity · doi:10.1002/oby.21069 · Cited by 208 · cited 1×
“Additionally, data on the correlation between measured plasma and cerebrospinal fluid OXT concentrations remains conflicting (289-295) and the pharmaco-kinetics of intranasal OXT is unclear (283, 285, 296-299).”
Havel, P. J., Uriu-Hare, J. Y., Liu, T., Stanhope, K. L., Stern, J. S., Keen, C. L., & Ahrén, B. (1998) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1998.274.5.r1482 · Cited by 198
Appetite controlled by a cholecystokinin nucleus of the solitary tract to hypothalamus neurocircuit
D'Agostino, G., Lyons, D. J., Cristiano, C., Burke, L. K., Madara, J. C., Campbell, J. N., Garcia, A. P., Land, B. B., Lowell, B. B., Dileone, R. J., et al. (2016) · eLife · doi:10.7554/elife.12225 · Cited by 193 · cited 7×
“Additionally, CCK is also expressed widely in the CNS, with high concentrations in the corpus striatum, hippocampus, hypothalamus, thalamus, basal ganglia, mesencephalon, and brainstem (particularly the NTS); in these regions, CCK-8 is predominant (172-175).”
InfluentialRole of melanocortin-4 receptors in mediating renal sympathoactivation to leptin and insulin
Rahmouni, K., Haynes, W. G., Morgan, D. A., & Mark, A. L. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-14-05998.2003 · Cited by 185
Kang, J. H., & Le, Q. A. (2017) · Medicine · doi:10.1097/md.0000000000008632 · Cited by 183
Metabolic surgery for the treatment of type 2 diabetes in obese individuals
Cummings, D. E., & Rubino, F. (2018) · Diabetologia · doi:10.1007/s00125-017-4513-y · Cited by 179
Efficacy and safety of intranasal peptide YY3-36 for weight reduction in obese adults
Gantz, I., Erondu, N., Mallick, M., Musser, B., Krishna, R., Tanaka, W. K., Snyder, K., Stevens, C., Stroh, M. A., Zhu, H., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1806 · Cited by 163 · cited 1×
“However, development of longer-term PYY-based therapies has been impeded by a lack of efficacy and side effects of nausea and vomiting (210, 211).”
Fekete, C., Mihály, E., Luo, L.-G., Kelly, J., Clausen, J. T., Mao, Q., Rand, W. M., Moss, L. G., Kuhar, M., Emerson, C. H., et al. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-24-09224.2000 · Cited by 163
Low CSF oxytocin reflects high intent in suicide attempters
Jokinen, J., Chatzittofis, A., Hellström, C., Nordström, P., Uvnäs-Moberg, K., & Åsberg, M. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2011.07.016 · Cited by 143
Burmeister, M. A., Ayala, J. E., Smouse, H., Landivar-Rocha, A., Brown, J. D., Drucker, D. J., Stoffers, D. A., Sandoval, D. A., Seeley, R. J., & Ayala, J. E. (2017) · Diabetes · doi:10.2337/db16-1102 · Cited by 136
Low plasma leptin levels contribute to diabetic hyperphagia in rats.
Sindelar, D. K., Havel, P. J., Seeley, R. J., Wilkinson, C. W., Woods, S. C., & Schwartz, M. W. (1999) · Diabetes · doi:10.2337/diabetes.48.6.1275 · Cited by 119
Tauber, M., Mantoulan, C., Copet, P., Jauregui, J., Demeer, G., Diene, G., Rogé, B., Laurier, V., Ehlinger, V., Arnaud, C., et al. (2011) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-6-47 · Cited by 117
LENG, G., ONAKA, T., CAQUINEAU, C., SABATIER, N., TOBIN, V, & TAKAYANAGI, Y. (2008) · Progress in brain research · doi:10.1016/s0079-6123(08)00413-5 · Cited by 112
Quintana, D. S., Westlye, L. T., Hope, S., Nærland, T., Elvsåshagen, T., Dørum, E., Rustan, Ø., Valstad, M., Rezvaya, L., Lishaugen, H., et al. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.103 · Cited by 111
Hamilton, J., Conwell, L., Syme, C., Ahmet, A., Jeffery, A., & Daneman, D. (2011) · International Journal of Pediatric Endocrinology · doi:10.1155/2011/417949 · Cited by 109 · cited 1×
“A similar strategy, using a combination of diazoxide (to reduce hyperinsulinemia) and metformin (to increase insulin sensitivity) also achieved relatively minimal results, but with the side effects of oedema and liver dysfunction (523).”
The interaction between the oxytocin and pain modulation in headache patients
Wang, Y.-L., Yuan, Y., Yang, J., Wang, C.-H., Pan, Y.-J., Lu, L., Wu, Y.-Q., Wang, D.-X., Lv, L.-X., Li, R.-R., et al. (2013) · Neuropeptides · doi:10.1016/j.npep.2012.12.003 · Cited by 107
Noble, E. E., Billington, C. J., Kotz, C. M., & Wang, C. (2014) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00118.2014 · Cited by 102 · cited 17×
“Abbreviations: 5-HT, serotonin; α MSH, α -melanocyte stimulating hormone; ACTH, adrenocorticotropic hormone; AgRP, Agouti-related peptide; ARC, arcuate nucleus; AVP, arginine–vasopressin; BDNF, brain-derived neurotrophic factor; BMI, body mass index; CART, cocaine-and amphetamine-regulated transcript; CCK, cholecystok…”
InfluentialAyala, J. E., Bracy, D. P., James, F. D., Burmeister, M. A., Wasserman, D. H., & Drucker, D. J. (2010) · Endocrinology · doi:10.1210/en.2010-0289 · Cited by 95
Impaired thermoregulatory ability of oxytocin-deficient mice during cold-exposure
KASAHARA, Y., TAKAYANAGI, Y., KAWADA, T., ITOI, K., & NISHIMORI, K. (2007) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.70498 · Cited by 89
Changes in cerebrospinal fluid neurochemistry during pregnancy
Altemus, M., Fong, J., Yang, R., Damast, S., Luine, V., & Ferguson, D. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.06.002 · Cited by 83
Hypothalamic proopiomelanocortin (POMC) neurons have a cholinergic phenotype
Meister, B., Gömüç, B., Suarez, E., Ishii, Y., Dürr, K., & Gillberg, L. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.05157.x · Cited by 75 · cited 1×
“In the central nervous sys-tem (CNS), Pomc expression is restricted to the ARC and NTS, both of which exhibit PC1 and PC2 activity, producing α -, β -, and γ MSH in the former, and α MSH and β -endorphin in the latter (91-93).”
Randomized controlled trial of Tesomet for weight loss in hypothalamic obesity
Huynh, K., Klose, M., Krogsgaard, K., Drejer, J., Byberg, S., Madsbad, S., Magkos, F., Aharaz, A., Edsberg, B., Tfelt-Hansen, J., et al. (2022) · European Journal of Endocrinology · doi:10.1530/eje-21-0972 · Cited by 43
Vasopressin and oxytocin in CSF and plasma of patients with aneurysmal subarachnoid haemorrhage
Martin, J., Kagerbauer, S. M., Schuster, T., Blobner, M., Kochs, E. F., & Landgraf, R. (2014) · Neuropeptides · doi:10.1016/j.npep.2013.12.004 · Cited by 40
Triiodothyronine supplementation for hypothalamic obesity
Fernandes, J. K., Klein, M. J., Ater, J. L., Kuttesch, J. F., & Vassilopoulou-Sellin, R. (2002) · Metabolism · doi:10.1053/meta.2002.35591 · Cited by 39
do Carmo, J. M., da Silva, A. A., Rushing, J. S., Pace, B., & Hall, J. E. (2013) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00518.2012 · Cited by 38
van Santen, H. M., Schouten-Meeteren, A. Y., Serlie, M., Meijneke, R. W. H., van Trotsenburg, A. S., Verberne, H., Holleman, F., & Fliers, E. (2015) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2014-0337 · Cited by 32
Dextroamphetamine Treatment in Children With Hypothalamic Obesity
van Schaik, J., Welling, M. S., de Groot, C. J., van Eck, J. P., Juriaans, A., Burghard, M., Oude Ophuis, S. B. J., Bakker, B., Tissing, W. J. E., Schouten-van Meeteren, A. Y. N., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.845937 · Cited by 30
Cited by
Hypothalamic obesity: from basic mechanisms to clinical perspectives
Argente, J., Farooqi, I. S., Chowen, J. A., Kühnen, P., López, M., Morselli, E., Gan, H.-W., Spoudeas, H. A., Wabitsch, M., & Tena-Sempere, M. (2025) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(24)00283-3 · Cited by 57
Self-citationMASLD: Prevalence, Mechanisms, and Sex-Based Therapies in Postmenopausal Women
Milani, I., Chinucci, M., Leonetti, F., & Capoccia, D. (2025) · Biomedicines · doi:10.3390/biomedicines13040855 · Cited by 38
“…receptors in the hypothalamus and hindbrain, including the paraventricular nucleus (PVN), dorsal medial nucleus of the hypothalamus and ARC, as well as the nucleus of the NTS, increasing satiety, reducing food intake [298,300,302], and potentially reducing anticipatory food reward [299,303].”
Semaglutide treatment of hypothalamic obesity – a real-life data study
Svendstrup, M., Rasmussen, A. K., Kistorp, C., Klose, M., & Andreassen, M. (2024) · Pituitary · doi:10.1007/s11102-024-01429-5 · Cited by 23
van Santen, H. M., & Müller, H. L. (2025) · Endocrine Reviews · doi:10.1210/endrev/bnaf025 · Cited by 21
The Intricate Relationship between Circadian Rhythms and Gastrointestinal Peptides in Obesity
Ribeiro, F. M., Arnaldo, L., P. Milhomem, L., S. Aguiar, S., & Franco, O. L. (2025) · Peptides · doi:10.1016/j.peptides.2025.171356 · Cited by 9
Metadata
- Authors
- Gan, H.-W., Cerbone, M., & Dattani, M. T.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2023-11-29
- Volume
- 45
- Issue
- 3
- Pages
- 309-342
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W4389132838
- Cited by
- 65
- References
- 127
- FWCI
- 7.53
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.